Pharma Journalist -

GSK and 23andMe unveiled an exclusive four-year collaboration that will focus on research and development of innovative new medicines and potential cures, using human genetics as the…
Read More...

Bristol-Myers Squibb Company and Tsinghua University, have entered into a collaboration to discover therapeutic agents against novel targets for autoimmune diseases and cancers. The…
Read More...

Athenex announced that both Phase 3 studies, KX-AK-003 and KX-AK-004, had achieved their primary endpoint of 100% clearance of actinic keratosis (AK) lesions at Day 57 within the face…
Read More...

STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API) manufacturing facility at Jinshan (Shanghai, China) has…
Read More...

LogiPharma (September 5-6, 2018 | Hilton Penn’s Landing, Philadelphia, PA) is the leading end-to-end supply chain event designed to help transform your supply chain. Each year, supply…
Read More...

LogiPharma (September 5-6, 2018 | Hilton Penn’s Landing, Philadelphia, PA) is the leading end-to-end supply chain event designed to help transform your supply chain. Each year, supply…
Read More...

Convelo Therapeutics, Inc. announced that it has launched from stealth mode with a mission to discover and develop a new class of medicines that regenerate the protective myelin coating…
Read More...

Pharmaceutical Product Development, LLC (PPD) has expanded its central lab technology capabilities integrated with Preclarus®, the comprehensive data solution that consolidates and…
Read More...

WuXi Biologics announced that the first GMP campaign in the new MFG3 facility was completed successfully. This 200,000 sq. ft. newly completed state-of-the-art clinical manufacturing…
Read More...

Q BioMed Inc. announced that it is extending its option agreement with Washington University in St. Louis. Under the agreement granting the exclusive right to license the technology, Q…
Read More...